Literature DB >> 31107251

Norovirus in health care and implications for the immunocompromised host.

Pearlie P Chong1, Robert L Atmar2,3.   

Abstract

PURPOSE OF REVIEW: The majority of norovirus outbreaks in the United States occur in healthcare facilities. With the growing population of immunocompromised hosts who are in frequent contact with healthcare facilities, norovirus is not only a threat to hospitals and nursing homes but also to these individuals. This review summarizes the impact of norovirus infection on healthcare facilities and immunocompromised hosts. RECENT
FINDINGS: The natural history of norovirus infection in immunocompromised individuals remains poorly understood. Although host immune responses play a critical role in reducing duration of viral shedding and viral load in norovirus-infected individuals, why some immunocompromised patients spontaneously recover while others develop a chronic and protracted course of illness remains unclear. Norovirus outbreaks occur in healthcare facilities because the virus is highly contagious, resistant to disinfection and efficiently transmitted. The use of real-time metagenomic next-generation sequencing and phylogenetic analyses has provided valuable information on transmission patterns in complex hospital-associated norovirus outbreaks. The development of human intestinal enteroid cultures enables the determination of effectiveness of disinfectants against human noroviruses, circumventing the validity questions with surrogate virus models due to differences in susceptibility to inactivation and disinfectants.
SUMMARY: Metagenomics next-generation sequencing can enhance our understanding of norovirus transmission and lead to more timely mitigation strategies to curb norovirus outbreaks in healthcare facilities. With new in-vitro cultivation methods for human noroviruses, candidate vaccines and effective antivirals could be available in the near future.

Entities:  

Mesh:

Year:  2019        PMID: 31107251      PMCID: PMC8191235          DOI: 10.1097/QCO.0000000000000557

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  105 in total

1.  Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007.

Authors:  J Joukje Siebenga; Harry Vennema; Du-Ping Zheng; Jan Vinjé; Bonita E Lee; Xiao-Li Pang; Eric C M Ho; Wilina Lim; Avinash Choudekar; Shobha Broor; Tamar Halperin; Nassar B G Rasool; Joanne Hewitt; Gail E Greening; Miao Jin; Zhao-Jun Duan; Yalda Lucero; Miguel O'Ryan; Marina Hoehne; Eckart Schreier; Rodney M Ratcliff; Peter A White; Nobuhiro Iritani; Gábor Reuter; Marion Koopmans
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

Review 2.  Enteric outbreaks in long-term care facilities and recommendations for prevention: a review.

Authors:  J D Greig; M B Lee
Journal:  Epidemiol Infect       Date:  2008-05-12       Impact factor: 2.451

Review 3.  Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities.

Authors:  Maria A Said; Trish M Perl; Cynthia L Sears
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

Review 4.  Prospects and Challenges in the Development of a Norovirus Vaccine.

Authors:  Nicolas W Cortes-Penfield; Sasirekha Ramani; Mary K Estes; Robert L Atmar
Journal:  Clin Ther       Date:  2017-07-26       Impact factor: 3.393

5.  An outbreak of norovirus infection in a bone marrow transplant unit.

Authors:  Manish Doshi; Simone Woodwell; Kimberly Kelleher; Kenneth Mangan; Peter Axelrod
Journal:  Am J Infect Control       Date:  2013-02-15       Impact factor: 2.918

6.  Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis.

Authors:  Lisa Swartling; Per Ljungman; Mats Remberger; Mikael Sundin; Annika Tiveljung; Jonas Mattsson; Elda Sparrelid
Journal:  Transpl Infect Dis       Date:  2018-02-26       Impact factor: 2.228

7.  Prevalence and characteristics of asymptomatic norovirus infection in the community in England.

Authors:  G Phillips; C C Tam; L C Rodrigues; B Lopman
Journal:  Epidemiol Infect       Date:  2010-03-03       Impact factor: 2.451

8.  Genetic Susceptibility to Norovirus GII.4 Sydney Strain Infections in Taiwanese Children.

Authors:  Li-Tzu Tu; Fu-Ping Liu; Yhu-Chering Huang; Chung-Guei Huang; Shuan Yang; Kuo-Chien Tsao; Ming-Wei Lai; Chih-Jung Chen
Journal:  Pediatr Infect Dis J       Date:  2017-04       Impact factor: 2.129

9.  Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012-2013.

Authors:  Eyal Leshem; Mary Wikswo; Leslie Barclay; Eric Brandt; William Storm; Ellen Salehi; Traci DeSalvo; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary A Booth; Christianne Biggs; Katie Garman; Amy M Woron; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

10.  Norwalk virus shedding after experimental human infection.

Authors:  Robert L Atmar; Antone R Opekun; Mark A Gilger; Mary K Estes; Sue E Crawford; Frederick H Neill; David Y Graham
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

View more
  5 in total

1.  Quantitative microbial risk assessment of human norovirus infection in environmental service workers due to healthcare-associated fomites.

Authors:  K N Overbey; G B Hamra; K E Nachman; C Rock; K J Schwab
Journal:  J Hosp Infect       Date:  2021-08-14       Impact factor: 3.926

Review 2.  Enteric Viral Co-Infections: Pathogenesis and Perspective.

Authors:  Heyde Makimaa; Harshad Ingle; Megan T Baldridge
Journal:  Viruses       Date:  2020-08-18       Impact factor: 5.048

3.  Fucoidan But Not 2'-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae.

Authors:  Malcolm Turk Hsern Tan; Yan Li; Mohamad Eshaghi Gorji; Zhiyuan Gong; Dan Li
Journal:  Viruses       Date:  2021-03-11       Impact factor: 5.048

Review 4.  Norovirus Vaccine: Priorities for Future Research and Development.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

5.  Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts.

Authors:  Amy Davis; Valerie Cortez; Marco Grodzki; Ronald Dallas; Jose Ferrolino; Pamela Freiden; Gabriela Maron; Hana Hakim; Randall T Hayden; Li Tang; Adam Huys; Abimbola O Kolawole; Christiane E Wobus; Melissa K Jones; Stephanie M Karst; Stacey Schultz-Cherry
Journal:  Viruses       Date:  2020-06-05       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.